N/A N=45 Preparing Medical Students to Undertake a First Female Pelvic Exam.
Female Pelvic Exam
Primary: Score on Pelvic Exam Assessment Tool — 23.9 points
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=131 Acellular Dermal Matrix in Primary Palatoplasty
Cleft Palate
Primary: Fistula Formation — 1; 8 participants
N/A N=74 UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation
Diabetes
Primary: To Compare Profiles of TCD-blood Flow Velocities (TCD_BFV). — 28.23; 33.11 cm/sec
N/A N=50 Efficacy of Fascia Iliaca Block Versus Intraoperative Nerve Infiltration During Anterior Hip Replacement Surgery
Pain, Postoperative
Primary: Postoperative Pain During PACU Admission — 40; 36 units on a scale
Phase 4 N=174 Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
Type 2 Diabetes
Primary: Percentage Change in Proteinuia — -23; -4 % change from baseline
Phase 3 N=383 Everolimus in de Novo Kidney Transplant Recipients
Kidney Transplantation
Primary: Percentage of Participants Without Wound Healing Complications - Worst-case Scenario — 68.39; 61.58 Percentage of participants — p=0.0921
N/A N=121 A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression
Depression
Primary: Beck Hopelessness Scale (BHS) — 4.888889; 4.428571 units on a scale
N/A N=99 Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
Dry Eye
Primary: Change From Baseline in Total Ocular Surface Staining (TOSS) Score at Day 42 — -1.16; -0.92 units on a scale
Phase 1 N=27 Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium Absorption
Healthy Volunteers
Primary: PTH AUC(0-6): Area Under the Serum Concentration-Time Curve From Time 0 to 6 Hours for Parathyroid Hormone — 215; 157 hour*picogram per milliliter (hr*pg/mL)
Phase 2 N=49 Staccato Alprazolam in Panic Attack
Treatment of Induced Panic Attack
Primary: Number of Participants With Doxapram-induced Panic Attack — 14; 9 Participants — p=0.200
N/A N=90 Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy
Fetal Heart Echocardiography by Five Dimensional Ultrasound
Primary: Number of Satisfactory Fetal Echocardiography Views by Two-Dimensional Ultrasound — 8.7 Number of satisfactory views
N/A N=167 Helius in Hypertension-I: The UK Hypertension Registry
Essential Hypertension
Primary: Frequency of Medication-taking (% Taking Adherence) — 75 percentage of taking adherence
Phase 3 N=316 Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®
Neutropenic Complications · Breast Neoplasms · Chemotherapy-induced Neutropenia
Primary: Mean Duration of Severe Neutropenia (DSN) During Cycle 1 of Chemotherapy — 0.75; 0.83; 0.75; 0.79 days — p=0.05
N/A N=30 In Vivo Investigation of Initial Stages of Enamel Erosion
Tooth Erosion
Primary: Change From Pre-acid Challenge (Baseline) Tooth Impression Grading Score Immediately Following an Acid Challenge — 3.75; 3.17 Scores on grading scale — p=0.2673
Phase 1 N=30 A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects
Asthma · Chronic Obstructive Pulmonary Disease (COPD)
Primary: Pharmacokinetics (PK) of AZD7594 Delivered by Monodose Inhaler and Multiple-dose DPI or pMDI in Terms of Pulmonary Bioavailability After Inhalation (Fpulmonary) — 27.49…